Diadema Partners’s Insmed INSM Stock Holding History

Diadema Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-52,800	Closed	-$9.19M	–	171
2025 Q4	$9.19M	Buy	+52,800	New	+$9.63M	1.58%	19
2025 Q1	–	Sell	-50,000	Closed	-$3.45M	–	130
2024 Q4	$3.45M	Buy	+50,000	New	+$3.6M	1.48%	21

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Diadema Partners's INSM Position: Q1 2025 in Review

Diadema Partners sold out of Insmed (INSM) in Q1 2025, closing a stake of 56,337 shares — an estimated $3.89M sold.

Diadema Partners first reported a position in INSM in Q4 2024 and held it in 1 quarter. The position peaked at $3.89M in Q4 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

Diadema Partners reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
Diadema Partners sold 56,337 Insmed shares in Q1 2025, an estimated $3.89M.
Diadema Partners first reported a position in Insmed in Q4 2024 and held it in 1 quarter.
Diadema Partners's Insmed position peaked at $3.89M in Q4 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Diadema Partners's 13F filing for Q1 2025, filed 15 May 2025.